Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathleen J Chavanu

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmacotherapy|November 16, 2002
Hormonal interventions for menstrual migrainesKathleen J Chavanu, Dannielle C O'Donnell
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 7, 2009
Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial studySteven G Chrysant, Kathleen J Chavanu, Jianbo Xu
The Senior Care Pharmacist|October 3, 2024
Paucity of Published Data and Protocols for Hypoglycemia Management in Long-term CareMatthew R Krecic, James Meyer, Kathleen J Chavanu
The American Journal of Cardiology|July 21, 2009
Comparison of olmesartan medoxomil versus amlodipine besylate on regression of ventricular and vascular hypertrophyClive Rosendorff, Robert Dubiel, Jianbo Xu, et al.
Postgraduate Medicine|June 14, 2012
Efficacy/safety of olmesartan medoxomil versus losartan potassium in patients by stage 1 or 2 hypertensionJohn M Flack, Alan Graff, Wei Li, et al.
Advances in Therapy|July 6, 2012
Efficacy/safety of olmesartan medoxomil versus losartan potassium in naïve versus previously treated subjects with hypertensionHenry A Punzi, Andrew Lewin, Wei Li, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 28, 2012
Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertensionF Wilford Germino, Joel M Neutel, Robert Dubiel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 6, 2009
Results of an olmesartan medoxomil-based treatment regimen in hypertensive patientsSuzanne Oparil, Steven G Chrysant, Dean Kereiakes, et al.
Postgraduate Medicine|February 5, 2011
A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertensionMatthew R Weir, Henry A Punzi, John M Flack, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmacotherapy|November 16, 2002
Hormonal interventions for menstrual migrainesKathleen J Chavanu, Dannielle C O'Donnell
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 7, 2009
Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial studySteven G Chrysant, Kathleen J Chavanu, Jianbo Xu
The Senior Care Pharmacist|October 3, 2024
Paucity of Published Data and Protocols for Hypoglycemia Management in Long-term CareMatthew R Krecic, James Meyer, Kathleen J Chavanu
The American Journal of Cardiology|July 21, 2009
Comparison of olmesartan medoxomil versus amlodipine besylate on regression of ventricular and vascular hypertrophyClive Rosendorff, Robert Dubiel, Jianbo Xu, et al.
Postgraduate Medicine|June 14, 2012
Efficacy/safety of olmesartan medoxomil versus losartan potassium in patients by stage 1 or 2 hypertensionJohn M Flack, Alan Graff, Wei Li, et al.
Advances in Therapy|July 6, 2012
Efficacy/safety of olmesartan medoxomil versus losartan potassium in naïve versus previously treated subjects with hypertensionHenry A Punzi, Andrew Lewin, Wei Li, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|August 28, 2012
Efficacy of olmesartan medoxomil and hydrochlorothiazide fixed-dose combination therapy in patients aged 65 years and older with stage 1 and 2 hypertension or isolated systolic hypertensionF Wilford Germino, Joel M Neutel, Robert Dubiel, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|January 6, 2009
Results of an olmesartan medoxomil-based treatment regimen in hypertensive patientsSuzanne Oparil, Steven G Chrysant, Dean Kereiakes, et al.
Postgraduate Medicine|February 5, 2011
A randomized, double-blind, forced-titration study to compare olmesartan medoxomil versus losartan potassium in patients with stage 1 and 2 hypertensionMatthew R Weir, Henry A Punzi, John M Flack, et al.
Pageof 1